Treatment of metastasized melanoma with combined checkpoint inhibition in a patient with highly active multiple sclerosis

MeSH terms

• Adult
• Antibodies, Monoclonal, Humanized / therapeutic use
• Antigens, CD20 / immunology
• Antineoplastic Agents, Immunological / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Brain Neoplasms / drug therapy*
• Brain Neoplasms / immunology
• Brain Neoplasms / secondary
• Chemotherapy, Adjuvant / methods
• Glucocorticoids / therapeutic use
• Humans
• Imidazoles / therapeutic use
• Interferon-beta / therapeutic use
• Male
• Melanoma / complications
• Melanoma / immunology
• Melanoma / secondary
• Melanoma / therapy*
• Multiple Sclerosis / complications
• Multiple Sclerosis / drug therapy
• Multiple Sclerosis / immunology*
• Neoplasm Recurrence, Local / complications
• Neoplasm Recurrence, Local / immunology
• Neoplasm Recurrence, Local / therapy*
• Oximes / therapeutic use
• Polyethylene Glycols / therapeutic use
• Pyridones / therapeutic use
• Pyrimidinones / therapeutic use
• Skin Neoplasms / complications
• Skin Neoplasms / immunology
• Skin Neoplasms / therapy*
• Treatment Outcome